In The News Posted July 12, 2019 Share Posted July 12, 2019 SAN FRANCISCO, July 11, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, alerts investors in automated medication supply manufacturer Omnicell, Inc. (NASDAQ: OMCL) to the firm's investigation of possible... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.